What Algreen does

Algreen B.V. is a Wageningen, Netherlands-based microalgae biotechnology consultancy founded in 2015 by Stefano Canziani and Hendrix. The firm provides B2B professional services to algae producers and biotechnology companies, covering the full project lifecycle from feasibility studies, contract research, and process benchmarking through PBR (photobioreactor) testing, regulatory and certification support (HACCP, EU Organic, US Organic NOP), cultivation process design, downstream processing, and full-scale production facility design. Its primary customers are microalgae producers seeking to scale from laboratory to industrial production, with secondary applications spanning the food, feed, pharmaceutical, and cosmetics industries using Spirulina, Galdieria, and Haematococcus-derived products.

The company's technical differentiation rests on expertise across three cultivation modes—autotrophic, heterotrophic, and mixotrophic—and on a portfolio of proprietary protocols. Notable proprietary assets include the "Future-Proof Protocol for Haematococcus" that achieves up to 5% astaxanthin accumulation within seven days, a closed photobioreactor mixotrophic system combining autotrophic and heterotrophic processes without costly ventilation, and an approach using food industry waste streams as substrate for Galdieria biomass production. Algreen maintains strain-selection competency for Spirulina, and is currently pursuing European Food Safety Authority (EFSA) approval for Galdieria as a novel food protein source.

Algreen generates revenue through professional consultancy and technical services invoiced per project, with 30-day payment terms and quote-based pricing. Its go-to-market is sales-led and consultative, leveraging the company's positioning within AlgaeParc 2.0 at Wageningen University and Research and its leadership roles in industry bodies including AISAM (Organic Committee chair), EABA, and the NEN Standardization Committee on Algae and Algae Products. The company operates with 1-10 employees, has supported more than 10 production facilities since inception, and counts a €11,473 StartLife pre-seed grant in July 2017 as its only disclosed external capital.

Name

Algreen

Legal name

Algreen B.V.

Website

https://algreen.eu

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Algreen B.V. is a Dutch microalgae biotechnology consultancy providing B2B services—including feasibility studies, production facility design, regulatory certification, and proprietary cultivation protocols—to algae producers scaling operations from laboratory to industrial scale.

Ownership category

akta.pro rank

Product category

Microalgae Biotechnology Consulting

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Seaweed & Algae Aquaculture (incl. microalgae) (AFAEAAAE)

akta.pro secondary industries

Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

Keywords

• Microalgae consulting
• Algae biotechnology services
• Cultivation process design
• Downstream processing services
• Organic certification support

Headquarters

HQ city

Wageningen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Consultancy and Technical Services: Professional consulting services including feasibility studies, process benchmarking, technical due diligence, and production facility design. Services are invoiced upon delivery with 30-day payment terms. Algreen operates as an independent contractor providing expertise to clients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Algreen B.V. provides B2B consultancy and technical services to microalgae producers, covering cultivation process design, downstream processing, feasibility studies, process benchmarking, PBR testing, contract research, production facility design, and regulatory certification support (HACCP, EU Organic, US Organic NOP). The company specializes in three algae strains — Spirulina, Galdieria, and Haematococcus — and supports clients in scaling from laboratory to industrial production.

Product overview

Algreen B.V. is a microalgae biotechnology consultancy company offering comprehensive services for the microalgae sector, including research, testing, and production facility design. The company specializes in three core algae strains: Spirulina (green-blue algae for nutrition), Galdieria (protein-rich algae), and Haematococcus (for astaxanthin production). Services include feasibility studies, contract research, process benchmarking, PBR testing, regulations and certifications support (HACCP, EU Organic, US Organic NOP), cultivation process design, downstream processing, and production facility design. Algreen supports over 10 production facilities and operates from AlgaeParc 2.0 at Wageningen University and Research in the Netherlands.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Services Feasibility studies, contract research, and process benchmarking to support microalgae project development from concept through scale-up, for algae producers and biotechnology companies.
• Testing Services Photobioreactor (PBR) testing and regulatory certification support covering HACCP, EU Organic, and US Organic NOP compliance for microalgae businesses.
• Production Facility Design Comprehensive production facility design including cultivation processes, downstream processing, and full facility engineering to scale microalgae operations from laboratory to industrial production, for algae producers and biotech companies.
• Regulation & Certification Support Support for navigating organic certification and ensuring compliance with industry regulations including EU Organic, US Organic NOP, HACCP, and food supplement regulations, for microalgae businesses.
• Spirulina Cultivation Program Spirulina cultivation program leveraging Algreen's state-of-the-art production protocol with strain selection and low-temperature drying to deliver high-quality Spirulina biomass for food, feed, pharmaceutical, and cosmetics industries.
• Galdieria Program Galdieria cultivation program using an innovative food-waste substrate approach to produce protein-rich biomass for food and feed applications, awaiting European Food Safety Authority approval as a protein source.
• Haematococcus Program Haematococcus pluvialis cultivation program applying Algreen's proprietary stress protocol to achieve up to 5% Astaxanthin accumulation within 7 days, serving nutraceutical, cosmetics, and aquaculture industries.

Quantifiable outcome

• Achieves up to 5% Astaxanthin accumulation within 7 days using proprietary stress protocol for Haematococcus pluvialis
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• AlgaeParc 2.0coreOthersAlgreen's facilities are located at AlgaeParc 2.0, the Algae Hub of Wageningen University and Research. This location provides access to cutting-edge technology and positions Algreen within a specialized innovation ecosystem for algae research and production.
• AISAM (Associazione Italiana Per Lo Studio E Le Applicazioni Delle Microalghe)coreStrategic or Co-development PartnerAlgreen is an active member of AISAM, chairing the Organic Committee (Comitato per il Biologico – ComBIO) and participating in the Industrial Committee (Comitato Industriale – ComIND). This positioning keeps Algreen at the forefront of industry standards and practices.
• EABA (European Algae Biomass Association)coreStrategic or Co-development PartnerAlgreen is a member of EABA, contributing to the European algae biomass sector and staying connected with industry developments and standards.
• NEN (Nederlands Normalisatie-instituut)minorStrategic or Co-development PartnerAlgreen participates in the NEN Standardization Committee on Algae and Algae Products, contributing to the development of industry standards and specifications.
• Wageningen University and ResearchcoreStrategic or Co-development PartnerAlgreen is co-located at AlgaeParc 2.0 within the Wageningen University and Research campus, providing access to academic expertise and research capabilities in the algae sector.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Algalif: Icelandic producer of premium astaxanthin from Haematococcus pluvialis and other microalgae ingredients. Comparable as a microalgae specialist working in the same Haematococcus/astaxanthin niche, representing a potential client for Algreen's cultivation and certification services.
• Fermentalg: French microalgae biotechnology company producing ingredients from microalgae for nutrition and health markets. Comparable as a European algae biotech with proprietary cultivation know-how and downstream processing capabilities serving similar B2B end-markets.
• Microphyt: French microalgae production company specializing in cultivation of microalgae for nutraceutical and cosmetic applications. Comparable as a European microalgae specialist with proprietary cultivation systems and downstream processing expertise overlapping Algreen's service portfolio.
• Photanol: Dutch microalgae company developing sustainable ingredients using proprietary cyanobacteria platforms. Comparable as a Netherlands-based algae biotech operating in the same Wageningen/Amsterdam innovation corridor with similar strain development and cultivation expertise.
• AlgaEnergy: Spanish microalgae biotechnology company developing microalgae-based products for agriculture, nutrition, and cosmetics. Comparable as a Europe-based microalgae specialist with cultivation expertise and downstream applications overlapping Algreen's Spirulina, Haematococcus, and Galdieria focus areas.

Broad incumbents

• Corbion: Dutch global ingredient company with an algae-derived ingredients platform (including AlgaPrime DHA). Comparable as a Netherlands-based, large-scale player in algae biotechnology whose cultivation and process development teams could overlap with Algreen's service offerings.
• Cyanotech: US-based producer of natural products from microalgae, including BioAstin (natural astaxanthin from Haematococcus pluvialis) and Spirulina Pacifica. Comparable as a vertically integrated Haematococcus and Spirulina specialist, representing the type of operator Algreen's facility-design services support.
• Roquette: Global leader in plant-based ingredients including algae-derived proteins and starches for food, nutrition, and pharma. Comparable as a major incumbent with overlapping algae protein interests (NUTRALYS, microalgae partnerships) that represents both a potential competitor and a large-scale client type.
• TerraVia: US-based (now part of Corbion) algae ingredients company with proprietary heterotrophic algae platform for food and personal care. Comparable as a larger-scale microalgae ingredients producer whose cultivation technology and process know-how overlap with Algreen's heterotrophic and mixotrophic expertise.

Others

• Royal HaskoningDHV: Dutch engineering and project management consultancy with food and bio-based process design capabilities. Comparable as an adjacent engineering services provider whose bioprocess and facility design teams could compete with or complement Algreen's production facility design offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/algreen-b-v
• Facebookfacebook.com/100054634381023

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Algreen